Augmentation strategies in clozapine-resistant schizophrenia

Area of Science:

• Psychiatry
• Pharmacology

Background:

• Antipsychotics revolutionized schizophrenia treatment, but many patients show suboptimal responses.
• Clozapine is effective for treatment-resistant schizophrenia, yet 40-70% still have inadequate responses.
• Augmentation strategies are explored for patients with suboptimal clozapine response.

Purpose of the Study:

• To review the evidence for augmentation strategies in patients with suboptimal response to clozapine.
• To guide clinicians on the cautious and systematic use of augmentation therapies.

Main Methods:

• Review of existing evidence, including smaller open trials, case series, and limited controlled studies.
• Analysis of the efficacy and risks associated with various augmentation strategies.

Main Results:

• Evidence for augmentation strategies is largely from less rigorous studies, though some controlled trials show positive findings.
• No single augmentation approach is definitively endorsed due to limited robust data.
• Potential for added adverse effects and clinical worsening exists.

Conclusions:

• Augmentation of clozapine should be approached cautiously and systematically.
• Rule out factors compromising clozapine response before considering augmentation.
• Augmentation trials require clear target symptoms, endpoints, and effective outcome evaluation to avoid polypharmacy and ensure benefit.